Vimarsana
Biggest News Aggregation in the World

Alan Hippe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alan Hippe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alan Hippe Today - Breaking & Trending Today

Roche : Invitation to Roche's Full Year Results 2023 Presentation -December 19, 2023 at 04:24 am EST - Vimarsana News

Roche : Invitation to Roche's Full Year Results 2023 Presentation -December 19, 2023 at 04:24 am EST

Roche will publish its Full Year Results of 2023 prior to the opening of the Swiss Stock Exchange on Thursday,1 February2024. 07:00 CET / 06:00 GMT / 01:00 AM EST...

Roche : Invitation to Roche's IR Digitalization Day -November 01, 2023 at 05:06 am EDT - Vimarsana News

Roche : Invitation to Roche's IR Digitalization Day -November 01, 2023 at 05:06 am EDT

We are pleased to invite investors and analysts to participate in a live webinar on Wednesday, 29 November 2023, highlighting Roche`s digital efforts in the...

Roche CFO flags need to bolster late-stage drug development - Vimarsana News

Roche CFO flags need to bolster late-stage drug development

FRANKFURT, July 27 - Swiss drugmaker Roche needs to have better drug development projects in advanced stages to bolster its battered stock...

Roche's 1H Earnings Decline On Lower COVID-19 Sales, CFO Says Late-Stage Pipeline Has Gaps That Needs To Be Filled - Roche Holding (OTC:RHHBF), Roche Holding (OTC:RHHVF), Roche Holding (OTC:RHHBY) - Vimarsana News

Roche's 1H Earnings Decline On Lower COVID-19 Sales, CFO Says Late-Stage Pipeline Has Gaps That Needs To Be Filled - Roche Holding (OTC:RHHBF), Roche Holding (OTC:RHHVF), Roche Holding (OTC:RHHBY)

Roche Holding AG (OTC: RHHBY) said sales for 1H 2023 dropped to CHF 30.62 billion from CHF 33.9 billion in the sam

UPDATE: As COVID Testing Demand Wanes, Roche Diagnostics Base Business Grows in First Half of 2023 - Vimarsana News

UPDATE: As COVID Testing Demand Wanes, Roche Diagnostics Base Business Grows in First Half of 2023

The company's overall revenues were down 8 percent to CHF 29.78 billion, although the base business excluding COVID-19 products grew 8 percent at constant exchange rates.